Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Real-World Study of EGFR-TKI Rechallenge with Another TKI after First-Line Osimertinib Discontinuation in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: A Subset Analysis of the Reiwa Study

Kei Sonehara,Kazunari Tateishi,Kiyotaka Yoh,Kazuhiro Usui,Yukio Hosomi,Kazuma Kishi,Go Naka,Kageaki Watanabe, Shu Tamano,Kohei Uemura,Hideo Kunitoh

THORACIC CANCER（2025）

Cited 0|Views3
Key words
epidermal growth factor receptor,non-small cell lung cancer,osimertinib,rechallenge,tyrosine kinase inhibitor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined